Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Chubb
Federal Trade Commission
Citi
Deloitte
Daiichi Sankyo
Colorcon
Cerilliant
Medtronic

Generated: November 18, 2018

DrugPatentWatch Database Preview

Cefdinir - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cefdinir and what is the scope of cefdinir freedom to operate?

Cefdinir is the generic ingredient in two branded drugs marketed by Aurobindo Pharma, Lupin, Orchid Hlthcare, Sandoz, Teva Pharms, and Abbvie, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for cefdinir. Thirty-one suppliers are listed for this compound.

Pharmacology for cefdinir
Synonyms for cefdinir
(-)-(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-oxime
(6R,7R,Z)-7-(2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetamido)-8-oxo-3-vinyl-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(N-hydroxyimino)acetamido]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-hydroxyimino-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-hydroxyimino-acetyl]amino]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-azanyl-1,3-thiazol-4-yl)-2-hydroxyimino-ethanoyl]amino]-3-ethenyl-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{2-(2-Amino-thiazol-4-yl)-2-[(Z)-hydroxyimino]-acetylamino}-8-oxo-3-vinyl-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(7R)-3-Vinyl-7-[[(2-amino-4-thiazolyl)[(E)-hydroxyimino]acetyl]amino]cepham-3-ene-4-carboxylic acid
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl) (hydroxyimino)acetyl)amino)-3-ethenyl-8-oxo-, (6R-(6alpha,7beta(Z)))-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(hydroxyiminoacetyl)amino)-3-ethenyl-8-oxo-, (6R-(6-alpha,7-beta(Z)))-
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-, (6R,7R)-
7-(2 (2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid
7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetamido]-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid
832C405
91832-40-5
A844075
AB01274720_02
AB01274720_03
AB01274720-01
AB1009352
ABP000637
AC1OCD3C
AK162391
AKOS015951262
AN-15138
BCP9000503
BCPP000293
BIDD:GT0827
BMY 28488
BMY-28488
BRD-K15766189-001-05-6
BSPBio_002735
C08110
C14H13N5O5S2
CCG-39455
Cefdiel
Cefdinir (JP15/USAN/INN)
Cefdinir (JP17/USAN/INN)
Cefdinir (Omnicef)
Cefdinir [USAN:INN]
Cefdinir [USAN:USP:INN:BAN]
Cefdinir monohydrate
Cefdinir, 97%
Cefdinir, Antibiotic for Culture Media Use Only
Cefdinir(Omnicef)
Cefdinir(Omnicef)/
Cefdinirum
Cefdinirum [INN-Latin]
Cefdinyl
Cefdirnir
cefnil
Ceftinex
Cefzon
Cefzon (TN)
CFDN
CHEBI:3485
CHEMBL927
CI 983
CI-983
CI0FAO63WC
cid_6915944
CPD000469224
CS-1925
D00917
D0WS1X
DB00535
DTXSID8046084
FK 482
FK-482
FR-80482
HMS1922L19
HMS2093K20
HY-B0136
KS-1038
LS-149988
MFCD00865030
MLS001304703
MLS001424233
MolPort-002-885-812
NCGC00178499-01
NSC-758926
NSC758926
Omnicef
Omnicef (TN)
Omnicef, FK-482, BMY-28488, PD 134393, CI-983, Cefdinir
PD 134393
PD-134393
Pharmakon1600-01505208
PubChem13658
s1605
SAM001246818
SBI-0206739.P001
SC-17007
SCHEMBL36995
SPECTRUM1505208
Spectrum5_001560
SR-05000001991
SR-05000001991-2
ST24046294
syn-7-[2-(2-Amino-4-thiazolyl)-2-hydroxyiminoacetamido]-3-vinyl-3-cephem-4-carboxylic acid; [6R-[6|A-7|A(Z)]]-7-[[(2-Amino-4-thiazolyl)(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxyl
UNII-CI0FAO63WC
X-2542
ZINC13119676

US Patents and Regulatory Information for cefdinir

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie OMNICEF cefdinir FOR SUSPENSION;ORAL 050749-002 Jul 29, 2004 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie OMNICEF cefdinir FOR SUSPENSION;ORAL 050749-001 Dec 4, 1997 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lupin CEFDINIR cefdinir CAPSULE;ORAL 065264-001 May 19, 2006 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie OMNICEF cefdinir CAPSULE;ORAL 050739-001 Dec 4, 1997 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Orchid Hlthcare CEFDINIR cefdinir CAPSULE;ORAL 065418-001 Jul 18, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma CEFDINIR cefdinir FOR SUSPENSION;ORAL 065473-001 Dec 14, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for cefdinir

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie OMNICEF cefdinir CAPSULE;ORAL 050739-001 Dec 4, 1997 ➤ Sign Up ➤ Sign Up
Abbvie OMNICEF cefdinir FOR SUSPENSION;ORAL 050749-002 Jul 29, 2004 ➤ Sign Up ➤ Sign Up
Abbvie OMNICEF cefdinir FOR SUSPENSION;ORAL 050749-001 Dec 4, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Chubb
Federal Trade Commission
Citi
Deloitte
Daiichi Sankyo
Colorcon
Cerilliant
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.